SCHEMBL1102787

SCHEMBL1102787

CC1(C)c2cc(-c3cccc4ccccc34)ccc2-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)C(C)(C)c4cc(-c6cccc7ccccc67)ccc4-5)c4cnccc34)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 3/20 0.45
BACE1 P56817 1/20 0.39
ENPP3 O14638 1/20 0.37
ENPP1 P22413 1/20 0.37
NTSR1 P30989 1/20 0.36
CHEK1 O14757 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
PIK3CD O00329 2/20 0.35
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MGAT2 Q10469 1/20 0.35
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103639 0.94 TNF (0.40) TNFBACE1ENPP3ENPP1NTSR1
SCHEMBL1102772 0.93 TNF (0.40) TNFBACE1ENPP3ENPP1MAPK11
SCHEMBL1103666 0.93 TNF (0.39) TNFBACE1ENPP3ENPP1NTSR1
SCHEMBL1103663 0.91 TNF (0.38) TNFBACE1NTSR1PIK3CDTLR8
SCHEMBL1104949 0.90 TNF (0.38) TNFBACE1ENPP3ENPP1MAPK11
SCHEMBL1102962 0.90 TNF (0.40) TNFBACE1ENPP3ENPP1NTSR1
SCHEMBL1102965 0.90 TNF (0.39) TNFBACE1ENPP3ENPP1CHEK1
SCHEMBL1102563 0.89 PDK2 (0.40) TNFPIK3CDPDK2
SCHEMBL1102896 0.89 TNF (0.39) TNFBACE1ENPP3ENPP1MAPK11
SCHEMBL1102676 0.88 CYP11B1 (0.41) TNFMAPK11MAPK14SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TNF 3803/4885BACE1 1597/4885ENPP3 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.